Back to News
Market Impact: 0.3
OrthoPediatrics Corp. Projects FY2026 Revenue of $270.0 to $273.0 Million
Source: Nasdaq
Corporate Guidance & OutlookCompany FundamentalsHealthcare & Biotech
OrthoPediatrics expects FY2026 revenue of $270.0 million to $273.0 million, representing total revenue growth of 14% to 16%. The article excerpt provides no comparison with prior guidance or additional details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
KIDS0.45
More News
- SK Hynix third-quarter profit sharply beats estimates on AI memory boost
- SK Hynix Posts Record Profit Amid AI Rush
- Anthropic's IPO could be 'speculative fiction' or a 'generational moment' — investors are split
- Anthropic Gives Traders a Pure-Play Bet on Frontier AI
- VCs will make billions on Anthropic’s IPO, but Amazon is set to make much (much) more
- Analysis-Hold or sell? High Treasury yields spur US banks to rethink bond portfolios